Balyasny Asset Management’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-993,429
| Closed | -$98.6M | – | 1648 |
|
|
2019
Q3 | $98.6M | Buy |
993,429
+377,766
| +61% | +$35.9M | 0.68% | 16 |
|
|
2019
Q2 | $56.9M | Buy |
615,663
+345,663
| +128% | +$32.8M | 0.36% | 53 |
|
|
2019
Q1 | $25.5M | Sell |
270,000
-56,627
| -17% | -$4.95M | 0.17% | 178 |
|
|
2018
Q4 | $20.9M | Buy |
326,627
+306,787
| +1,546% | +$22.6M | 0.15% | 191 |
|
|
2018
Q3 | $1.77M | Buy |
19,840
+1,175
| +6% | +$104K | 0.01% | 1023 |
|
|
2018
Q2 | $1.48M | Sell |
18,665
-419,474
| -96% | -$34.8M | 0.01% | 1029 |
|
|
2018
Q1 | $39.1M | Buy |
438,139
+218,848
| +100% | +$21M | 0.16% | 173 |
|
|
2017
Q4 | $22.9M | Sell |
219,291
-87,120
| -28% | -$9.83M | 0.07% | 360 |
|
|
2017
Q3 | $44.7M | Sell |
306,411
-81,105
| -21% | -$11M | 0.18% | 156 |
|
|
2017
Q2 | $50.3M | Buy |
387,516
+158,092
| +69% | +$19.4M | 0.21% | 124 |
|
|
2017
Q1 | $28.5M | Sell |
229,424
-615,630
| -73% | -$73.7M | 0.13% | 199 |
|
|
2016
Q4 | $97.8M | Buy |
845,054
+485,317
| +135% | +$54M | 0.53% | 22 |
|
|
2016
Q3 | $37.6M | Buy |
359,737
+31,806
| +10% | +$3.44M | 0.22% | 145 |
|
|
2016
Q2 | $32.3M | Buy |
327,931
+316,667
| +2,811% | +$32.8M | 0.21% | 129 |
|
|
2016
Q1 | $1.13M | Buy |
11,264
+8,028
| +248% | +$827K | 0.01% | 755 |
|
|
2015
Q4 | $388K | Sell |
3,236
-104,842
| -97% | -$12.1M | ﹤0.01% | 898 |
|
|
2015
Q3 | $11.7M | Buy |
108,078
+48,228
| +81% | +$5.98M | 0.09% | 304 |
|
|
2015
Q2 | $6.93M | Buy |
+59,850
| New | +$6.84M | 0.04% | 502 |
|
|
2013
Q3 | – | Sell |
-127,680
| Closed | -$7.47M | – | 834 |
|
|
2013
Q2 | $7.47M | Buy |
+127,680
| New | +$7.68M | 0.13% | 199 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Balyasny Asset Management's CELG Position: Q4 2019 in Review
Balyasny Asset Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 993,429 shares — an estimated $98.6M sold.
Balyasny Asset Management first reported a position in CELG in Q2 2013 and held it in 19 quarters. The position peaked at $98.6M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Balyasny Asset Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Balyasny Asset Management sold 993,429 Celgene Corp shares in Q4 2019, an estimated $98.6M.
- Balyasny Asset Management first reported a position in Celgene Corp in Q2 2013 and held it in 19 quarters.
- Balyasny Asset Management's Celgene Corp position peaked at $98.6M in Q3 2019.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Balyasny Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.